OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 5.96
+0.18 (3.11%)
Feb 11, 2026, 9:36 AM CET
OncoZenge AB Revenue
OncoZenge AB had revenue of 2.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 2.78M, up 69,475.00% year-over-year. In the year 2024, OncoZenge AB had annual revenue of 1,000.00, down -66.67%.
Revenue (ttm)
2.78M
Revenue Growth
+69,475.00%
P/S Ratio
26.27
Revenue / Employee
2.78M
Employees
1
Market Cap
73.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | -2.00K | -66.67% |
| Dec 31, 2023 | 3.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| Scandinavian ChemoTech AB | 11.68M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.80M |
| Spago Nanomedical AB | 5.84M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 957.89K |